Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2009Podcast to be Available Following Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m.
EST on Thursday, February 5, 2009 to discuss the company’s financial
results for its third quarter of fiscal 2009. Management will review the
quarter and provide an update on the company.
The conference call will be webcast on the investor relations section of
Alkermes’ website at www.alkermes.com
or may be accessed by dialing 1-866-219-5260 for domestic callers and
1-703-639-1117 for international callers. The conference call ID number
A replay of the conference call will be available from 7:30 p.m. EST on
Thursday, February 5, 2009 through 5:00 p.m. EST on Thursday, February
12, 2009, and may be accessed by visiting Alkermes’ website or by
dialing 1-888-266-2081 for domestic callers and 1-703-925-2533 for
international callers. The replay access code is 1328237. Alkermes is
also providing a podcast MP3 file available for download on the Alkermes
website, which will be available shortly following the conference call
and will be available until Thursday, February 12, 2009.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA® for
schizophrenia. Alkermes' robust pipeline includes extended-release
injectable, pulmonary and oral products for the treatment of prevalent,
chronic diseases, such as central nervous system disorders, addiction
and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has
research facilities in Massachusetts and a commercial manufacturing
facility in Ohio.
Source: Alkermes, Inc.
Eva Stroynowski, 617-583-6823